Effective Post-Exposure Treatment of Ebola Infection

• Heinz Feldmann ,

  Contributed equally to this work with: Heinz Feldmann, Steven M Jones

  *To whom correspondence should be addressed. E-mail: Heinz_Feldmann@phac-aspc.gc.ca (HF); Steven_Jones@phac-aspc.gc.ca (SMJ)

  Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• Steven M Jones ,

  Contributed equally to this work with: Heinz Feldmann, Steven M Jones

  *To whom correspondence should be addressed. E-mail: Heinz_Feldmann@phac-aspc.gc.ca (HF); Steven_Jones@phac-aspc.gc.ca (SMJ)

  Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada, Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• Kathleen M Daddario-DiCaprio,

  Affiliations Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America

  ⨯
• Joan B Geisbert,

  Affiliation Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

  ⨯
• Ute Ströher,

  Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• Allen Grolla,

  Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• Mike Bray,

  Affiliation Biodefense Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Elizabeth A Fritz,

  Affiliation Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

  ⨯
• Lisa Fernando,

  Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• Friederike Feldmann,

  Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• Lisa E Hensley,

  Affiliation Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

  ⨯
• Thomas W Geisbert

  Affiliations Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America

  ⨯